Drug Trial Radar · NCT04461535
Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism(ADOPA)
Last checked: Nov 19, 2026Latest source record: Dec 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
228
Actual
Start
Jul 8, 2020
Primary completion
Feb 20, 2023
Study completion Feb 20, 2023
Sponsor
- Lead sponsor
- Chongqing Medical UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 8, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Diagnostic
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To compare the effect of different procedures of AVS(with or without ACTH stimulation) on the long-term outcomes of patients with PA
Conditions
- Primary Aldosteronism
Interventions
Adrenocorticotropic hormoneDrug
Patients divided into Intervention group need to undergo stimulation with a continuous cosyntropin infusion (50 μg/h started 30 minutes before sampling during AVS). Right and left adrenal venous blood and corresponding peripheral venous blood should be sampled sequentially.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Compare the proportion of surgically treated patients with complete biochemical remission in the overall cohort between two groupsTime frame: At 12 months of follow-up.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The First Affilated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.